Effects of Remimazolam on Quality of Recovery After Ambulatory Surgery

Seoul National University

Status

Completed

Conditions

Remimazolam

Quality of Recovery

Day Surgery

Patient Outcome Assessment

Treatments

Drug: Remimazolam

Study type

Observational

Funder types

Other

Identifiers

NCT05320016

B-2109-708-309

Details and patient eligibility

About

Remimazolam is a novel ultra-short acting benzodiazepine with rapid onset of effects, short maintenance and faster recovery time. Due to its recent development, few studies have investigated the effect of remimazolam on postoperative recovery mainly focusing on physiologic endpoints, recovery time and possible adverse events. Although these parameters are crucial and need evaluation, the investigators ignore quality of recovery from participant's perspective. For this purpose, various measurment tools have been developed for psychometric evaluation of QoR score.

Full description

To date, there has not been a study investigating the impact of remimazolam on quality of recovery (QoR). This study evaluates the effect of remimazolam on QoR of participants undergoing general anesthesia using remimazolam-remifentanil total intravenous anesthesia (TIVA) for hysteroscopy as day surgery basis. Herein, the investigators used the translated Korean version of the 15-item Quality of Recovery-15 (QoR-15K) questionnaire, which was previously validated in Korean surgical participants.

Enrollment

38 patients

Sex

Female

Ages

19 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria